U.S. regulators defend requiring more data on monkeypox drug

U.S. regulators defend requiring more data on monkeypox drug To win approval, SIGA Chief Scientific Officer Dennis Hruby estimates it will likely take a 500-patient, placebo-controlled clinical trial in the United States. https://ift.tt/tz7djYP